结论大肝癌应积极地进行手术切除。
Conclusions It is advisable to resect large hepatocellular carcinoma actively.
大肝癌：不能切除如何办？
目的探讨以手术为主的系列疗法治疗原发性大肝癌的方法及疗效。
Objective To discuss the methods and effects of a series of surgery oriented therapies in the treatment of large primary liver cancers.
目的：探讨肝动脉结扎插管术在治疗“大肝癌”中的原理和价值。
Objective: to evaluate the principle and efficacy of hepatic artery ligation and intubation to large HCC.
目的：改进微波肝组织凝固技术，为该技术在治疗大肝癌的应用奠定基础。
Objective:The aim of this study was to improve the technique of percutaneous microwave coagulation therapy( PMCT) in the treatment of the patients with large liver cancers.
目的：评价腹腔镜引导下微波消融作为治疗非手术适应证大肝癌的临床疗效。
Objective:To investigate the effect of microwave ablation in big liver cancer guided by laparoscopy.
结论大肝癌术前TACE使肝功能受损，增加手术难度及手术风险，并有可能耽误手术时机。
Conclusion Preoperative TACE for resectable large HCC damages liver function, increases surgical difficulty and risk, maybe delay operation chance.
结论采用TAE、SPVE及RFA一次定位多点穿刺法治疗无手术切除指征的中晚期(含大肝癌)的病人，疗效明显，总并发症发生率低。
The methods of one localization and multiple puncture RFA combined with TAE and SPVE improved the curative effects in the treatment of large liver tumor greatly, and the complications are less.
全球范围内男性5大常见癌症杀手为（按比率排序）：肺癌、胃癌、肝癌、肠癌和食道癌。
Worldwide, the 5 most common types of cancer that kill men are (in order of frequency): lung, stomach, liver, colorectal and oesophagus.
在肝癌介入微波热凝固疗法中，肝癌肿瘤的不规则性是治疗中的一大难题。
The abnormity of the liver tumor is a difficult problem in the invasive microwave coagulation.
原发性肝癌(HCC)是目前世界上十大恶性肿瘤之一，而慢性乙型肝炎病毒(HBV)感染是导致HCC最主要的原因之一。
Primary hepatocellular carcinoma (HCC) is one of the top 10 malignant tumors worldwide, and chronic infection with HBV is one of the major causes of HCC.
一位健康专家昨天指出，每天喝一品脱的啤酒，一大杯的葡萄酒，或几量杯的烈酒会增加至20%的患肝癌和肠癌风险。
Drinking one pint of beer, a large glass of wine or a couple of measures of spirits a day increases the risk of liver and bowel cancers by a fifth, a health expert warned yesterday.
这种新型的小鼠模型将有利于针对肝癌—人类癌症死亡的第三大杀手进行药物的研制和测试。
The new mouse model is also likely to facilitate development and testing of new drugs to target liver cancer, which is the third leading cause of cancer deaths worldwide.
肝癌是世界第五大常见癌症且是第三大杀手。
HCC is the fifth most common cancer and the third most frequent cause of cancer death worldwide.
索拉非尼改善了患者生存期，虽然不是很明显，但却是肝癌治疗的一大进步，同时也激发了晚期肝癌一线治疗药物的开发。
The improvement insurvival facilitated by sorafenib, even though modest, was a major advance for the treatment of HCC, and stimulated drug development in first line treatment of HCC.
索拉非尼改善了患者生存期，虽然不是很明显，但却是肝癌治疗的一大进步，同时也激发了晚期肝癌一线治疗药物的开发。
The improvement insurvival facilitated by sorafenib, even though modest, was a major advance for the treatment of HCC, and stimulated drug development in first line treatment of HCC.
应用推荐